These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6199200)

  • 21. The inhibition of tissue activator and urokinase by human plasma.
    Walker JE; Ogston D
    Thromb Haemost; 1982 Jun; 47(3):265-8. PubMed ID: 6180497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of polymyxin B and colimycin on induction of plasminogen antiactivator by lipopolysaccharide in human endothelial cell culture.
    Dubor F; Dosne AM; Chedid LA
    Infect Immun; 1986 Jun; 52(3):725-9. PubMed ID: 3011672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased synthesis of fibrinolytic inhibitor induced by muramyl dipeptide derivatives in human cultured endothelial cells.
    Dosne AM; Dubor F; Terrier M; Dupuy E; Chedid L
    Int J Immunopharmacol; 1985; 7(2):225-30. PubMed ID: 3924845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators.
    Levin EG; Loskutoff DJ
    J Cell Biol; 1982 Sep; 94(3):631-6. PubMed ID: 6813340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the catalytic activity of plasminogen activator under physiologic conditions.
    Aggeler J; Risch J; Werb Z
    Biochim Biophys Acta; 1981 Jun; 675(1):62-8. PubMed ID: 6455162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and partial characterization of plasminogen activator from human uterine tissue.
    Rijken DC; Wijngaards G; Zaal-de Jong M; Welbergen J
    Biochim Biophys Acta; 1979 Sep; 580(1):140-53. PubMed ID: 121055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cultured granulosa cells produce two plasminogen activators and an antiactivator, each regulated differently by gonadotropins.
    Ny T; Bjersing L; Hsueh AJ; Loskutoff DJ
    Endocrinology; 1985 Apr; 116(4):1666-8. PubMed ID: 3918858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of plasminogen activators from human seminal plasma.
    Propping D; Zaneveld LJ; Tauber PF; Schumacher GF
    Biochem J; 1978 May; 171(2):435-44. PubMed ID: 26336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralization of human extrinsic (tissue-type) plasminogen activator in human plasma: no evidence for a specific inhibitor.
    Korninger C; Collen D
    Thromb Haemost; 1981 Oct; 46(3):662-5. PubMed ID: 6171907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the human tissue plasminogen activator in plasma from different species.
    Häggroth L; Mattsson C; Friberg J
    Thromb Res; 1984 Mar; 33(6):583-94. PubMed ID: 6202022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 1 preferentially stimulates the production of tissue-type plasminogen activator by human articular chondrocytes.
    Bunning RA; Crawford A; Richardson HJ; Opdenakker G; Van Damme J; Russell RG
    Biochim Biophys Acta; 1987 Jun; 924(3):473-82. PubMed ID: 3109496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S; Müllertz S; Suenson E; Kok P
    Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
    Wijngaards G
    Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator.
    Lijnen HR; Nelles L; Van Hoef B; De Cock F; Collen D
    Thromb Haemost; 1988 Oct; 60(2):247-50. PubMed ID: 3146141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
    Wohlwend A; Belin D; Vassalli JD
    J Exp Med; 1987 Feb; 165(2):320-39. PubMed ID: 2434595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator.
    Booth NA; Anderson JA; Bennett B
    J Clin Pathol; 1984 Jul; 37(7):772-7. PubMed ID: 6235248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.
    Vassalli JD; Dayer JM; Wohlwend A; Belin D
    J Exp Med; 1984 Jun; 159(6):1653-68. PubMed ID: 6374011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells.
    Strickland DK; de Serrano VS; Chan SY; Pollard M; Castellino FJ
    Biochemistry; 1983 Sep; 22(19):4444-9. PubMed ID: 6684952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibody that specifically inhibits a human Mr 52,000 plasminogen-activating enzyme.
    Kaltoft K; Nielsen LS; Zeuthen J; Danø K
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3720-3. PubMed ID: 6808514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.